Evidence map›Paper›PMID 31518003›Full record

ArticleTransfusion2019

Lack of persistent microchimerism in contemporary transfused trauma patients.

Rachael P Jackman, Garth H Utter, Tzong-Hae Lee, Lani Montalvo, Li Wen, Dan Chafets, Ryan M Rivers, Patricia M Kopko, Philip J Norris, Michael P Busch

Abstract read
In one paragraph

Article in Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Identifying Key Questions and Challenges in Microchimerism Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rachael P JackmanVitalant Research Institute, San Francisco, California.ORCID 0000-0001-8591-7819
Garth H UtterUniversity of California, Davis, Medical Center, Sacramento, California.
Tzong-Hae LeeVitalant Research Institute, San Francisco, California.
Lani MontalvoVitalant Research Institute, San Francisco, California.
Li WenVitalant Research Institute, San Francisco, California.
Dan ChafetsVitalant Research Institute, San Francisco, California.
Ryan M RiversUniversity of California, Davis, Medical Center, Sacramento, California.
Patricia M KopkoUniversity of California, San Diego, California.
Philip J NorrisVitalant Research Institute, San Francisco, California.
Michael P BuschVitalant Research Institute, San Francisco, California.

Funding

Mechanisms and clinical effects of microchimerism in transfused trauma patientsR01HL083388 · NHLBI · VITALANT · PI BUSCH, MICHAEL PAUL · 2006 to 2010
$5.7M
NHLBI NIH HHS R01 HL083388
6 · The paper itself

Abstract

backgroundFollowing transfusion, donor white blood cells (WBCs) can persist long-term in the recipient, a phenomenon termed transfusion-associated microchimerism (TA-MC). Prior studies suggest TA-MC is limited to transfusion following traumatic injury, and is not prevented by leukoreduction. STUDY DESIGN AND

methodsWe conducted a prospective cohort study at a major trauma center to evaluate TA-MC following injury. Index samples were collected upon arrival, prior to transfusion. Follow-up samples were collected at intervals up to one year, and beyond for those testing positive for TA-MC. TA-MC was detected by real-time quantitative allele-specific polymerase chain reaction assays at the HLA-DR locus and several polymorphic insertion deletion sites screening for non-recipient alleles.

resultsA total of 378 trauma patients were enrolled (324 transfused cases and 54 non-transfused controls). Mean age was 42 ± 18 years, 74% were male, and 80% were injured by blunt mechanism. Mean Injury Severity Score was 20 ± 12. Among transfused patients, the median (interquartile range) number of red cell units transfused was 6 (3,12), and median time to first transfusion was 9 (0.8,45) hours. Only one case of long-term TA-MC was confirmed in our cohort. We detected short-term TA-MC in 6.5% of transfused subjects and 5.6% on non-transfused controls.

conclusionsIn contrast to earlier studies, persistent TA-MC was not observed in our cohort of trauma subjects. Short-term TA-MC was detected, but at a lower frequency than previously observed, and rates were not significantly different than what was observed in non-transfused controls. The reduction in TA-MC occurrence may be attributable to changes in leukoreduction or other blood processing methods.

Indexed as

ChimerismAdultFemaleHumansInjury Severity ScoreMaleMiddle AgedProspective StudiesTransfusion ReactionWounds and Injuries

Identifiers

PMID31518003
PMCPMC7408297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.